(*) CA Approval Date: 2020. 12
(*) CA Launch Date: 2021. 03.16
>Human IGF-1 Inj.
Company
Generic Name: mecasermin
IGF: insulin-like growth factor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2022. 07.26
RTM
RTM Web-Site
SPIGFD: severe primary insulin-like